Home/Hedge Fund Intelligence/10x Genomics, Inc.
Nasdaq: TXGStockForm 13F30 Jun 2026

Hedge funds that hold 10x Genomics, Inc. Class A Com Nasdaq: TXG

Class A Com · CUSIP 88025U109 · who reports it, how much, and how much it matters to them

31 of the 720 hedge fund managers we track reported shares of 10x Genomics, Inc. (Nasdaq: TXG) on Form 13F for 30 June 2026. Between them they reported USD 373m. The largest position belongs to Citadel Advisors, at USD 107m. The manager with the most riding on it is Blue Water Life Science Advisors, where it is 15.5% of the reported book.

Managers reporting it31of 720 we track
Value they reportUSD 373mshares only, 30 Jun 2026
Funds they run398with a file on PPLI.com
Largest positionUSD 107mCitadel Advisors
Typical weight0.0%median share of a manager's book
Heaviest weight15.5%Blue Water Life Science Advisors

Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated

Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.

13F
What this page is

A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.

Who holds it

31 managers, USD 373m between them

Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.

Every manager that reports 10x Genomics, Inc., largest position first

The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.

#ManagerValue reportedShare of its book
1Citadel Advisors32 funds on PPLI.comUSD 107m0.0%
2POINT72 Asset Management17 funds on PPLI.comUSD 71m0.1%
3Casdin Capital3 funds on PPLI.comUSD 40m2.0%
4Anomaly Capital Management1 fund on PPLI.comUSD 33m1.3%
5Renaissance Technologies13 funds on PPLI.comUSD 31m0.0%
6Blue Water Life Science Advisors3 funds on PPLI.comUSD 25m15.5%
7Samlyn Capital8 funds on PPLI.comUSD 19m0.3%
8D. E. Shaw & Co.15 funds on PPLI.comUSD 8.9m0.0%
9Two Sigma Investments35 funds on PPLI.comUSD 5.4m0.0%
10Millennium Management6 funds on PPLI.comUSD 4.5m0.0%
11Exome Asset Management2 funds on PPLI.comUSD 3.9m2.4%
12Campbell & Company Investment Adviser8 funds on PPLI.comUSD 3.9m0.2%
13J. Goldman & Co.1 fund on PPLI.comUSD 3.2m0.1%
14Prelude Capital Management9 funds on PPLI.comUSD 3m0.2%
15Brevan Howard Capital Management39 funds on PPLI.comUSD 3m0.0%
16Engineers Gate Manager1 fund on PPLI.comUSD 2.3m0.0%
17Squarepoint Ops7 funds on PPLI.comUSD 2.1m0.0%
18Pinnbrook Capital Management1 fund on PPLI.comUSD 1.6m0.2%
19Cinctive Capital Management5 funds on PPLI.comUSD 922,0000.0%
20Brandywine Managers47 funds on PPLI.comUSD 726,0000.4%
21Arrowmark Colorado Holdings24 funds on PPLI.comUSD 619,0000.0%
22Landscape Capital Management4 funds on PPLI.comUSD 613,0000.0%
23Bridgewater Associates45 funds on PPLI.comUSD 513,0000.0%
24Diametric Capital2 funds on PPLI.comUSD 482,0000.1%
25Exoduspoint Capital Management7 funds on PPLI.comUSD 271,0000.0%
26Capstone Investment Advisors25 funds on PPLI.comUSD 271,0000.0%
27Caxton Associates6 funds on PPLI.comUSD 232,0000.0%
28Bayforest Capital1 fund on PPLI.comUSD 222,0000.2%
29Voleon Capital Management13 funds on PPLI.comUSD 212,0000.0%
30Persistent Asset Partners10 funds on PPLI.comUSD 28,9470.0%
31Walleye Capital8 funds on PPLI.comUSD 3,8340.0%
Next: where it matters most
Where it matters most

For Blue Water Life Science Advisors it is 15.5% of the book

A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.

#ManagerValue reportedShare of its book
1Blue Water Life Science AdvisorsUSD 25m15.5%
2Exome Asset ManagementUSD 3.9m2.4%
3Casdin CapitalUSD 40m2.0%
4Anomaly Capital ManagementUSD 33m1.3%
5Brandywine ManagersUSD 726,0000.4%
6Samlyn CapitalUSD 19m0.3%
7Prelude Capital ManagementUSD 3m0.2%
8Campbell & Company Investment AdviserUSD 3.9m0.2%
9Bayforest CapitalUSD 222,0000.2%
10Pinnbrook Capital ManagementUSD 1.6m0.2%
Next: how to read this
How to read this

What a 13F list can and cannot tell you

  • It is the manager's filing, not a fund's. Form 13F covers every account a firm runs. We cannot say which of its funds holds the shares.
  • It is a snapshot. The list shows the last day of the quarter. A manager may have bought or sold since, and trading inside the quarter leaves no trace.
  • It shows one side. Short positions, swaps and shares listed outside the United States are not reported, so a manager on this list may be hedged or net short.
  • It covers the managers we track. Our coverage is 720 managers of hedge and private funds. Banks, index funds and other institutions that file Form 13F are not counted here.
Next: questions
Questions

Questions about who holds 10x Genomics, Inc.

What is the ticker symbol of 10x Genomics, Inc.?

10x Genomics, Inc. trades under the symbol TXG on the Nasdaq. Its CUSIP, the code used on Form 13F, is 88025U109.

Which hedge funds own 10x Genomics, Inc. (Nasdaq: TXG)?

31 of the 720 hedge fund managers PPLI.com tracks reported 10x Genomics, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Citadel Advisors (USD 107m), POINT72 Asset Management (USD 71m), Casdin Capital (USD 40m), Anomaly Capital Management (USD 33m) and Renaissance Technologies (USD 31m).

How many hedge funds hold 10x Genomics, Inc.?

31 managers in our coverage reported it, and between them they run 398 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.

Which manager has the most riding on 10x Genomics, Inc.?

Blue Water Life Science Advisors, where the position was 15.5% of the reported 13F book at 30 June 2026.

Does this show who is short 10x Genomics, Inc.?

No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.

Important information

Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with 10x Genomics, Inc. or with the managers listed.

Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.

Private consultation →
Step 1 of 2

Tell us about yourself

Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.

✦Research assistant
✦PPLI.comResearch assistant
Explore PPLI questions and suitability factors
Ask a general question about PPLI, or explore the factors that affect suitability. Treat the answer as a starting point and check the linked sources.
Use the research with your own tax, legal and insurance advisers.
Preparing an answer
AI assistant. Educational information only. It does not determine eligibility or provide personal tax, legal, investment or insurance advice.